OptimizeRx Corp — Director's Dealing 2020

Mar 13, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2020-03-11

Reporting Person: Silvestro Stephen L (CHIEF COMMERCIAL OFFICER)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-03-11	Stock Option	$7.51	A	105933	Acquired	2025-03-11	Common Stock (105933)	Direct

Footnotes

F1: The Stock Option will vest 25% at the end of each quarter starting on 3/31/2020.